Suppr超能文献

抗利尿药物(氯磺丙脲、卡马西平、氯贝丁酯)对垂体性尿崩症患者残余抗利尿激素产生永久性增强作用的证据。

Evidence for permanent enhancement of residual ADH induced by antidiuretic agents (chlorpropamide, carbamazepine, clofibrate) in patients with pituitary diabetes insipidus.

作者信息

Radó J P

出版信息

Endokrinologie. 1975 Jan;64(2):217-22.

PMID:1149696
Abstract

Excretion of free water was studied in 7 patients with pituitary diabetes insipidus before treatment and after withdrawal of antidiuretic drugs (chlorpropamide, carbamazepine, clofibrate) used on a long-term basis. A statistically significant decrease in free water clearance was found after 2-4 weeks of withdrawal of antidiuretic agents. This was considered as a clinical evidence for the permanently enhanced release of residual ADH induced by chlorpropamide, carbamazepine and clofibrate in patients with partial defect in ADH secretion.

摘要

对7例垂体性尿崩症患者在治疗前以及停用长期使用的抗利尿药物(氯磺丙脲、卡马西平、氯贝丁酯)后,研究其自由水排泄情况。停用抗利尿药物2 - 4周后,发现自由水清除率有统计学意义的下降。这被视为氯磺丙脲、卡马西平及氯贝丁酯在抗利尿激素分泌存在部分缺陷的患者中诱导残余抗利尿激素持续释放增强的临床证据。

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验